Badger Meter holds a leading position in North American water metering and AMI — the networked systems of smart meters, communications, and software that utilities use to monitor and manage water delivery. The company's durable competitive advantages include proprietary cellular communication technology, deep integration with municipal utility workflows, and a "Choice Matters" meter portfolio that lets customers select hardware independent of the network platform.
The medium-term story is a deliberate evolution from selling meters to selling a full water-intelligence platform. Its BlueEdge suite unifies metering, sensors, connectivity, and analytics, while acquisitions of SmartCover Systems and UK-based UDLive have built global leadership in sewer-line and collection-system monitoring. Management frames this as expanding from a $5 billion to $15 billion total addressable market, and it targets high-single-digit organic revenue growth alongside double-digit growth in software and "Beyond the Meter" solutions over the next several years. The strategic logic is clear: recurring software revenue carries higher margins, improves customer stickiness, and smooths out the lumpiness inherent in large, project-driven hardware deployments. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Structural risks include competition from larger water-technology peers, the inherently uneven timing of multi-year utility projects, and a premium valuation that leaves limited room for execution missteps.
The most significant near-term catalyst is the ramp of recently awarded AMI projects, most notably the PRASA contract — one of the largest smart-meter deployments globally — where initial shipments began in 2026 and revenue is expected to scale through 2027 and beyond. Management has cited a project pipeline of roughly 2.6 million to 3.6 million connections, well above the cohort that drove growth from 2023 to 2025. The pace and timing of these deployments will shape both top-line growth and investor sentiment, with any slippage potentially pushing revenue into 2027.
Quarterly earnings reports remain key inflection points, given the business's project-driven variability. Watch items include short-cycle order trends, gross-margin performance against copper and tariff pressures, and the trajectory of software and recurring revenue. Capital allocation is another lever: with no outstanding debt, roughly $500 million in available capital, and a 33-year streak of dividend increases, management has ample capacity for further disciplined M&A or share repurchases. From what I see, this balance-sheet strength stands out as a key differentiator.
Analyst sentiment has turned more mixed and polarized. Several firms — including Argus Research, RBC Capital, Seaport Global, and Stifel — maintain Buy ratings, with recent target raises into the $168–$187 range. In contrast, Barclays holds a contrarian Underweight stance with a target near $112, citing valuation concerns. Consensus still leans "Buy," but the wide dispersion underscores genuine disagreement about whether structural growth justifies the multiple.
Badger Meter's trajectory is closely tied to durable, secular demand drivers rather than discretionary consumer cycles: aging water infrastructure, workforce churn at utilities, water-scarcity concerns, and tightening environmental regulation all push municipal customers toward digitization. These forces tend to be resilient across economic cycles, lending the business a defensive quality.
That said, macro conditions matter at the margin. Elevated interest rates can influence municipal borrowing capacity and the financing of large capital projects, potentially affecting the timing of AMI deployments. Commodity prices — copper in particular — and shifting tariff policy directly pressure input costs, a risk management seeks to offset through pricing and product mix. Inflation dynamics also shape utility budgets. Geopolitical tensions and trade policy could further complicate the supply chain, even as the company's predominantly U.S.-based revenue base provides some insulation. The accelerating adoption of cellular AMI and software analytics remains the dominant structural tailwind.
Looking toward 2026 and beyond, the central question is whether Badger Meter can convert its expanded opportunity set into sustained, higher-quality growth. Management's multi-year framework targets high-single-digit organic revenue growth, 10–15% earnings-per-share growth, and free cash flow conversion above 100% of net income — a profile supported by its 39–42% gross-margin range and rising software contribution.
Several long-term themes will shape the outcome. First, market expansion: international penetration and the newer sewer-monitoring and water-quality categories offer meaningful runway beyond the mature North American metering base. Second, margin sustainability: as software and recurring revenue scale, incremental margins should structurally improve, but this hinges on disciplined pricing amid commodity and tariff volatility. Third, technology transitions: the shift to cellular AMI and cloud analytics favors incumbents with embedded utility relationships and installed hardware bases. Fourth, competitive threats: larger, well-capitalized water-technology rivals could intensify pricing pressure or bundle competing software. Finally, capital allocation: with a strong balance sheet and no debt, strategic acquisitions remain a double-edged sword — capable of accelerating growth or, if poorly integrated, diluting returns.
Consensus analyst expectations reflect cautious optimism: long-run revenue estimates project a return to growth, and the prevailing "Buy" consensus implies confidence in the multi-year story despite near-term choppiness. The premium valuation, however, means the market is already pricing in successful execution, leaving the stock sensitive to project timing, margin delivery, and any resolution of the outstanding securities litigation. I'm watching this closely as project ramps unfold.
In my analysis of names like Badger Meter, I often turn to Tickeron’s Trend Prediction Engine to get an additional data-driven perspective on potential short-term movements. It helps surface developing trends and complements the fundamental work on project pipelines and margin dynamics. This tool has become a regular part of how I cross-check technical signals against the longer-term story.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for BMI crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on BMI as a result. In 55 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.
BMI moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in 184 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 110 of 211 cases where BMI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.
The 10-day RSI Indicator for BMI moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 15 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 63 cases where BMI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 63%.
The Moving Average Convergence Divergence Histogram (MACD) for BMI turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 23 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 49%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
BMI broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. BMI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 71 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock better than average.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.714) is normal, around the industry mean (1.448). P/E Ratio (36.786) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (2.931) is also within normal values, averaging (5.470). Dividend Yield (0.011) settles around the average of (0.012) among similar stocks. P/S Ratio (4.255) is also within normal values, averaging (32.028).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a maker of flow measurement and control products
Industry ElectronicEquipmentInstruments